Annette Torgunrud

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritonei.

Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritonei.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: February 23, 2026

The specificity of HEG1 as mesothelioma marker depends on the differential diagnosis.

The specificity of HEG1 as mesothelioma marker depends on the differential diagnosis.

Journal: Virchows Archiv : an international journal of pathology
Published: October 14, 2025

High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies.

High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies.

Journal: Pleura and peritoneum
Published: September 19, 2025

Enrichment of Cancer-Associated Fibroblasts, Macrophages, and Up-Regulated TNF-α Signaling in the Tumor Microenvironment of CMS4 Colorectal Peritoneal Metastasis.

Enrichment of Cancer-Associated Fibroblasts, Macrophages, and Up-Regulated TNF-α Signaling in the Tumor Microenvironment of CMS4 Colorectal Peritoneal Metastasis.

Journal: Cancer medicine
Published: August 29, 2024

Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer.

Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer.

Journal: Annals of surgery
Published: August 26, 2024

Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer.

Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer.

Journal: Journal of translational medicine
Published: March 20, 2024

Molecular characteristics of tubo-ovarian carcinosarcoma at different anatomic locations.

Molecular characteristics of tubo-ovarian carcinosarcoma at different anatomic locations.

Journal: Virchows Archiv : an international journal of pathology
Published: March 11, 2024

Different Frequency and Clinical Role for MTAP Loss in Pleural and Peritoneal Mesothelioma.

Different Frequency and Clinical Role for MTAP Loss in Pleural and Peritoneal Mesothelioma.

Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: December 04, 2023

External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification.

External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: November 02, 2022

Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritonei.

Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritonei.

Journal: Pleura and peritoneum
Published: October 25, 2022

Molecular characteristics of low-grade serous carcinoma in effusions.

Molecular characteristics of low-grade serous carcinoma in effusions.

Journal: Cytopathology : official journal of the British Society for Clinical Cytology
Published: October 05, 2022

T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases.

T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases.

Journal: GigaScience
Published: September 30, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026